Copied from Croda's web site, it gives a quick insight into the niche markets in which this company specialises ...... They also own Uniquema, which is how the latter fits in ......

Croda isnt a household name but household names have made us successful. Within our core speciality chemicals business we focus on personal care, health care, home care and plastics additive markets.

Uniqema (cynic adds - acquisition completed 1/9/06) provides base oleochemicals such as fatty acids, polymerised fatty acids, glycerine and soap to a global market. With years of experience and technical advancements, Uniqema is a global market leader.


Now you have the outline, here are the charts to follow ..... Croda has generally been a steady performer, and none the worse for it ...... the chart today, following the announcement of a sale of a part of the biz, sp has moved upwards with indications that it could be about to break upwards .... and i have backed my mouth with my money

Have held for a long time and the Uniqema purchase from ICI has had fairly transformational effect. Debt quite high after the acquisition, but cash generation strong and IMO a good share for PEP/ISA, but always DYOR.

Superb figures yesterday and interim divi up 25%. EPS for current year could well reach 50p. IMO a quality stock for long term investors, but always DYOR.

had forgotten about this one but I see it has performed well .... good looking chart and pattern

Recent bullish Broker coverage..

Croda International PLC

FORECASTS
2008 2009

Date Rec Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

Charles Stanley
30-01-09 BUY 97.00 49.00 18.90 112.00 55.00 21.80

W H Ireland Ltd
29-01-09 BUY 98.00 43.60 18.60 111.00 54.50 20.50

ABN AMRO
05-01-09 BUY 97.50 47.16 18.60 99.34 48.21 20.46

Collins Stewart
05-12-08 BUY 49.80 56.30

2008 2009
Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

Consensus 97.50 47.92 18.60 111.44 55.26 20.48
1 Month Change 0.00 0.08 0.00 0.01 0.55 0.00
3 Month Change 1.30 1.69 -0.01 2.05 1.76 -0.19


GROWTH
2007 (A) 2008 (E) 2009 (E)

Norm. EPS 17.23% 46.94% 15.32%
DPS 6.96% 27.40% 10.11%

INVESTMENT RATIOS
2007 (A) 2008 (E) 2009 (E)

EBITDA 116.90m 146.63m 158.35m
EBIT 85.40m m m
Dividend Yield 2.74% 3.49% 3.84%
Dividend Cover 2.23x 2.58x 2.70x
PER 16.36x 11.13x 9.65x
PEG 0.95f 0.24f 0.63f
Net Asset Value PS 9.85p 152.49p 179.41p

Comment

27-01-09 27.01.09 :+6, (492.75) JP Morgan cuts Croda price target to 650p from 670p

A 650p price target with results coming up 17/2/2009

Looks bullish to me.

edited..

From todays Daily Telegraph..

City Comment: An opportunity missed to grill bankers in detail about their role in crisis; Landlords fear Stylo deal sets precedent; Not a lot to offer Grainger investors

Feature Column by Sir Nigel Rudd, chairman of BAA: When the new economic dawn comes, we must be the first to see the sun

Questor: Petrofac Hold; Croda - Buy

ABN AMRO, new Broker info yesterday..

Croda International PLC

FORECASTS
2008 2009

Date Rec Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

ABN AMRO
10-02-09 BUY 97.50 47.16 18.60 99.34 48.21 20.46

Charles Stanley
30-01-09 BUY 97.00 49.00 18.90 112.00 55.00 21.80

W H Ireland Ltd
29-01-09 BUY 98.00 43.60 18.60 111.00 54.50 20.50

Collins Stewart
05-12-08 BUY 49.80 56.30

2008 2009
Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

Consensus 97.50 47.90 18.60 111.45 54.72 20.48
1 Month Change 0.00 0.06 0.00 0.04 0.02 0.00
3 Month Change 1.30 1.67 -0.01 2.05 1.23 -0.19


GROWTH
2007 (A) 2008 (E) 2009 (E)

Norm. EPS 17.23% 46.88% 14.24%
DPS 6.96% 27.40% 10.11%

INVESTMENT RATIOS
2007 (A) 2008 (E) 2009 (E)

EBITDA 116.90m 146.64m 158.35m
EBIT 85.40m m m
Dividend Yield 2.83% 3.60% 3.96%
Dividend Cover 2.23x 2.58x 2.67x
PER 15.84x 10.78x 9.44x
PEG 0.92f 0.23f 0.66f
Net Asset Value PS 9.85p 152.49p 179.41p

hi gf
looks good at moment. hold/wait before buying is my take on this.could be wrong of course,.
as always lets all door.
regards
jkd

Hi JKD, yes a solid stratergy.

Could be a run up to the results soon.

regards Gf.

ta Gf
no doubt questor might prove me wrong. i do hope so for all investors sake.
bring back the real quiny. questor aint the same. give im a rise and bring im back. lol.
regards
jkd

Croda International PLC

FORECASTS
2008 2009

Date Rec Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

ABN AMRO
10-02-09 BUY 97.50 47.16 18.60 99.34 48.21 20.46

it's certainly a very good company this, but though i started the thread, i have not been watching it of late ...... though i have some cash in hand, shall sit and contemplate for the moment, though good friend GF (nice to have someone who also gets lots of flak!) has guided me well of late

well, i suppose i half-reciprocated with ORE, which i still highly commend as it is still showing a discount of about 10% to the all-share offer from POG

Nice one cyners.

oh you silver-tongued devil you!

haven't seen the figures, but thought they were very good .... so sp has plummeted! ..... selling on the news? ..... maybe a good chance to buy?

bought a few at 493.5 (see chart above), and may come back for a second bite

Exactly what I did cyners.

Opens up a chance to re- buy after the ships steadied a little.

Bumper profits, divi up 25% and confident about 2009 prospects, so shares go down! Fly in the ointment appears to be rising debt, primarily because of adverse currency translation (which also helped profits) and there is still a significant pension deficit. Cash generation is strong, the business looks to be very well managed and in good long term markets. A quality share imo.

From the Blue Index Blog

Chemical Brother
April 29th, 2009

Chemical group Croda (CRDA) is one of those less-than-glamorous companies, often ignored as traders and investors chase more adventurous plays. But a closer look at the Croda share price performance shows a resilient performance throughout the credit crinch, and a healthy dividend to boot

This morning, Croda announced Q1 pre-tax profits for continuing operations of GBP21.7m, on revenues from continuing operations up 1.9% to 230.8m. These numbers are also boosted 20.1% thanks to some favourable currency transactions, and more importantly are in line with expectations. Group net debt at 395.8m at the end of March, is also in line. While the group expects weakness in the commodity and industrial markets to continue, Croda anticipates sales growth in its Consumer Care and this, says the group, allied to ongoing cost savings and favourable raw material pricing in some sectors, gives continued confidence for further progress in 2009.

Full transcript here
http://blog.blueindex.co.uk/2009/04/chemical-brother/